MercadoLibre (MELI) Releases Financial Results for Q1 2026
MercadoLibre posted Q1 2026 revenue of $8.845 billion, up 49% year‑over‑year and 46% on an FX‑neutral basis. Net income reached $417 million, delivering a 4.7% profit margin, while operating income fell 20% to $611 million, compressing the operating margin to 6.9%. The company highlighted strong fintech momentum, with monthly active users climbing to 83 million, a 29% increase YoY, driven largely by Brazil. Management emphasized long‑term investments over short‑term profitability to sustain growth across its commerce and fintech platforms.
Uber Technologies (UBER) Raises Stake in Delivery Hero SE, Reports Bloomberg
Uber Technologies increased its ownership of German food‑delivery firm Delivery Hero to 19.5% and secured an additional 5.6% in options, valuing the company at €33 ($38.29) per share. The stake boost follows DoorDash’s acquisition of Deliveroo and aims to strengthen...
Roth Capital Lifts PT on The Beachbody Company (BODI) Post Q1
Roth Capital raised its price target for The Beachbody Company (BODI) to $13 from $10 while keeping a neutral rating, citing continued weakness in legacy businesses and uncertain product velocity. On the same day, Noble Capital upgraded its outlook, lifting...
Lake Street Remains Bullish on Velo3D, Inc. (VELO) Post Q1 Results
Lake Street raised its price target on Velo3D (NASDAQ:VELO) to $20 from $18 and kept a Buy rating after the company posted its fiscal Q1 2026 results. Revenue climbed to $13.8 million, a 48% year‑over‑year increase, while gross margin reached 17.2%....
Forum Energy Technologies (FET) Reports 8% Revenue Growth in Q1
Forum Energy Technologies (FET) posted Q1 2026 revenue of $209 million, an 8% year‑over‑year rise, and net income of $4 million, or $0.39 per diluted share. Adjusted for restructuring, net income was $6 million, or $0.47 per share, while adjusted EBITDA climbed 14%...
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG
BTIG upgraded Cerus Corporation (CERS) to Buy on May 1, keeping its $4 price target after the company posted strong fiscal Q1 2026 results. Total revenue rose 23% year‑over‑year to $59.9 million, while product revenue climbed 24% to $53.7 million. The firm also lifted...
Why Upstart (UPST) Still Has an AI-Lending Moonshot Case
Upstart Holdings posted first‑quarter revenue of $308 million, a 44% year‑over‑year increase, while loan transaction volume surged 77% to 425,356 loans and total originations climbed 61% to roughly $3.4 billion. The company reaffirmed its 2026 outlook of about $1.4 billion in revenue and...
Why Lucid (LCID) Is Becoming a Robotaxi Moonshot
Lucid announced that Uber will raise its total investment to $500 million and commit to purchasing at least 35,000 vehicles for a future global robotaxi service, covering the Gravity SUV and upcoming midsize models. The same update included a $550 million infusion...
11 Largest Uranium Producing Countries in the World
The article outlines the 11 largest uranium‑producing nations, noting that the top three account for roughly 75% of the 60,213 tonnes of uranium mined annually, which meets about 90% of nuclear utility demand. In‑situ recovery now dominates the sector, supplying over...
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook
Medicus Pharma Ltd. (MDCXW) announced FDA clearance to launch a Phase 2b dose‑optimization trial of its Teverelix candidate in advanced prostate cancer, alongside new protocols for benign prostatic hyperplasia urinary retention. The company also reported encouraging Phase 2 data for a doxorubicin...
ZoomInfo Tech (GTM) Reports Q1 2026 GAAP Revenue of $310.2M
ZoomInfo Technologies reported Q1 2026 GAAP revenue of $310.2 million, a modest 1.5% year‑over‑year increase. GAAP operating income rose 15% to $57.9 million (19% margin) while adjusted operating income climbed 9% to $109.7 million, delivering a 35% margin. The company generated $114.7 million...
Newell Brands (NWL) Reports Q1 2026 Net Sales of $1.5B
Newell Brands posted Q1 2026 net sales of $1.5 billion, a modest 1.1% year‑over‑year decline, while core sales slipped 3.5%. The company narrowed its GAAP loss to $33 million, or $0.08 per share, and lifted operating margin to 2.2% through pricing and...
MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2M
MannKind Corp. posted Q1 2026 revenue of $90.2 million, a 15% rise year‑over‑year, driven by $15.5 million in Furoscix sales and higher Tyvaso DPI royalties. R&D expenses jumped 56% to $17.2 million and SG&A surged 116% to $54.1 million after acquiring scPharma and preparing for...
Compass Therapeutics (CMPX) Reports Q1 2026 Net Loss of $18.3M
Compass Therapeutics reported a Q1 2026 net loss of $18.3 million, or $0.10 per share, as R&D expenses rose to $13.4 million and G&A costs jumped 41 percent to $6.9 million. The company ended the quarter with $195 million in cash and marketable securities, extending...
Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M
Palisade Bio reported Q1 2026 results, with research and development expenses climbing to $6.4 million, up from $1.0 million a year earlier. The rise reflects higher staffing, chemistry, manufacturing, and clinical trial costs for its lead candidate PALI-2108. The company...